Various substitutes of brachytherapy boost after neoadjuvant chemoradiation for locally advanced cervical cancer. Literature Review

Main Article Content

Eter Natelauri
Krystyna Kiel
Tea Natelauri
Tinatin Liluashvili
Tornike Badzgaradze
Jarji Batsikadze
Zurab tcheishvili
Nika Targaladze


Objective: Concurrent chemoradiotherapy (CCRT) is widely regarded as the gold standard for locally advanced cervical cancer (LACC). Radio Therapy encompasses pelvic external beam radiation therapy (EBRT), followed by intracavitary brachy therapy (BT) to boost the cervix. However, in developing countries, there is a tendency to prefer surgery over other types of treatments for several reasons - surgery is easily obtainable, more acceptable, and understandable culturally. On the other hand, in developed countries, The utilization of brachy therapy (BT) to boost the cervix in patients with Cervical Cancer (CC) has been gradually declined because of the advent of sophisticated techniques for EBRT. Recently, the treatment of LACC has been a point of controversy. We have no prospective data to justify that surgery or modern EBRT can be used in place of intracavitary BT boost in women with locally advanced CC. This study aims to review existing information about brachytherapy alternatives after neoadjuvant chemoradiation.

Material and Methods: An electronic search of the PubMed database was conducted to obtain key cervical cancer literature. The MEDLINE/PubMED ( database was chosen as it remains the most widely used resource for medical literature. Additional records were searched in other resources.

Results: The first phase of screening identified 18 articles for the first search term (“Adjuvant hysterectomy” AND “Cervical Cancer”), 10 article for the second search term (“IMRT boost” AND Cervical cancer”) and 11 articles for the third search term (“SBRT” AND “Cervical Cancer”). In sum 39 articles were identified to be relevant for the second phase of screening. Studies that included less than five patients with investigated intervention or did not provided enough information about at least one primary endpoint were excluded. A total of 20 (11-adjuvant hysterectomy, 4-IMRT boost, 5-SBRT boost) papers met the selection criteria and were found eligible for this review. 

Conclusion: When all these alternative approaches to ICB are evaluated, adjuvant hysterectomy appears to have treatment outcomes comparable to standard of care, while SBRT appears to have only modest yearly results. As a result, the majority of writers believe that neoadjuvant chemoradiation followed by radical surgery or SBRT may be a realistic therapeutic option for patients with LACC, not merely when ICB is unavailable, technically impractical, or rejected. Large, randomized-controlled trials are required to conclusively demonstrate or invalidate non-ICB alternatives for cervical cancer treatment.


Download data is not yet available.

Article Details

How to Cite
Natelauri, E., Kiel, K., Natelauri, T., Liluashvili, T., Badzgaradze, T., Batsikadze, J., Tcheishvili, Z., & Targaladze, N. (2022). Various substitutes of brachytherapy boost after neoadjuvant chemoradiation for locally advanced cervical cancer. Literature Review. Medical Science and Discovery, 9(3), 201–213.
Review Article
Received 2022-03-05
Accepted 2022-03-20
Published 2022-03-26


Burghardt E, Pickel H. Local spread and lymph node involvement in cervical cancer. Obstetrics and Gynecology. 1978 Aug 1;52(2):138-45.

Hilaris BS, Nori D, Anderson LL. An atlas of brachytherapy. MacMillan Publishing Company; 1988.

Hacker NF, Wain GV, Nicklin JL. Resection of bulky positive lymph nodes in patients with cervical carcinoma. International Journal of Gynecologic Cancer. 1995 Jun 1;5(4).

Morice P, Castaigne D, Pautier P, Rey A, Haie-Meder C, Leblanc M, Duvillard P. Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecologic oncology. 1999 Apr 1;73(1):106-10.

KENTER GG, HELLEBREKERS BW, ZWINDERMAN KH, VAN DE VIJVER MA, PETERS LA, TRIMBOS JB. The case for completing the lymphadenectomy when positive lymph nodes are found during radical hysterectomy for cervical carcinoma. Acta obstetricia et gynecologica Scandinavica. 2000 Jan;79(1):72-6.

Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, Fitch K, Harkenrider MM, Holschneider CH, Kamrava M, Leung E. Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline. Practical radiation oncology. 2020 Jul 1;10(4):220-34.

Tsuda H, Tanaka M, Manabe T, Nakata S, Ishiko O, Yamamoto K. Phase I-II study of neoadjuvant chemoradiotherapy followed by radical surgery in locally advanced cervical cancer. Anti-cancer drugs. 2001 Nov 1;12(10):853-8.

Decker MA, Burke II JJ, Gallup DG, Silverio RW, Weems D, Duttenhaver J, Purcell D. Completion hysterectomy after radiation therapy for bulky cervical cancer stages IB, IIA, and IIB: complications and survival rates. American journal of obstetrics and gynecology. 2004 Aug 1;191(2):654-8.

Ferrandina G, Legge F, Fagotti A, Fanfani F, Distefano M, Morganti A, Cellini N, Scambia G. Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures. Gynecologic oncology. 2007 Oct 1;107(1):S127-32.

Fanfani F, Fagotti A, Ferrandina G, Raspagliesi F, Ditto A, Cerrotta AM, Morganti A, Smaniotto D, Scambia G. Neoadjuvant chemoradiation followed by radical hysterectomy in FIGO Stage IIIB cervical cancer: feasibility, complications, and clinical outcome. International Journal of Gynecologic Cancer. 2009 Jul 1;19(6).

Ferrandina G, Margariti PA, Smaniotto D, Petrillo M, Salerno MG, Fagotti A, Macchia G, Morganti AG, Cellini N, Scambia G. Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery. Gynecologic oncology. 2010 Dec 1;119(3):404-10.

Ferrandina G, Gambacorta A, Gallotta V, Smaniotto D, Fagotti A, Tagliaferri L, Foti E, Fanfani F, Autorino R, Scambia G, Valentini V. Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study. International Journal of Radiation Oncology* Biology* Physics. 2014 Nov 15;90(4):778-85.

Cetina L, González-Enciso A, Cantú D, Coronel J, Pérez-Montiel D, Hinojosa J, Serrano A, Rivera L, Poitevin A, Mota A, Trejo E. Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2–IIB cervical cancer patients. Annals of oncology. 2013 Aug 1;24(8):2043-7.

Dueñas-González A, Cetina-Perez L, Lopez-Graniel C, Gonzalez-Enciso A, Gómez-Gonzalez E, Rivera-Rubi L, Montalvo-Esquivel G, Muñoz-Gonzalez D, Robles-Flores J, Vazquez-Govea E, de La Garza J. Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized phase II study. International Journal of Radiation Oncology* Biology* Physics. 2005 Mar 1;61(3):817-23.

Gallotta V, Ferrandina G, Chiantera V, Fagotti A, Fanfani F, Ercoli A, Legge F, Costantini B, Alletti SG, Bottoni C, Anchora LP. Laparoscopic radical hysterectomy after concomitant chemoradiation in locally advanced cervical cancer: a prospective phase II study. Journal of Minimally Invasive Gynecology. 2015 Jul 1;22(5):877-83.

Rema P, Suchetha S, Kumar A, Ahmed I. The role of adjuvant hysterectomy after radiotherapy in cervical cancer. Indian Journal of Surgery. 2015 Dec;77(3):902-5.

Hass P, Eggemann H, Costa SD, Ignatov A. Adjuvant hysterectomy after radiochemotherapy for locally advanced cervical cancer. Strahlentherapie und Onkologie. 2017 Dec;193(12):1048-55.

Yoshida K, Kajiyama H, Yoshihara M, Tamauchi S, Ikeda Y, Yoshikawa N, Nishino K, Niimi K, Suzuki S, Kikkawa F. The role of additional hysterectomy after concurrent chemoradiation for patients with locally advanced cervical cancer. International Journal of Clinical Oncology. 2020 Feb;25(2):384-90.

Castro JR, Issa P, Fletcher GH. Carcinoma of the cervix treated by external irradiation alone. Radiology. 1970 Apr;95(1):163-6.

Ulmer HU, Frischbier HJ. Treatment of advanced cancers of the cervix uteri with external irradiation alone. International Journal of Radiation Oncology* Biology* Physics. 1983 Jun 1;9(6):809-12.

Montana GS, Fowler WC, Varia MA, Walton LA, Mack Y, Shemanski L. Carcinoma of the cervix, stage III. Results of radiation therapy. Cancer. 1986 Jan 1;57(1):148-54.

Barraclough LH, Swindell R, Livsey JE, Hunter RD, Davidson SE. External beam boost for cancer of the cervix uteri when intracavitary therapy cannot be performed. International Journal of Radiation Oncology* Biology* Physics. 2008 Jul 1;71(3):772-8.

Park HC, Shimizu S, Yonesaka A, Tsuchiya K, Ebina Y, Taguchi H, Katoh N, Kinoshita R, Ishikawa M, Sakuragi N, Shirato H. High dose three-dimensional conformal boost using the real-time tumor tracking radiotherapy system in cervical cancer patients unable to receive intracavitary brachytherapy. Yonsei Medical Journal. 2010 Jan 31;51(1):93-9.

Matsuura K, Okabe T, Fujita K, Tanimoto H, Akagi Y, Kagemoto M. Clinical results of external beam radiotherapy alone with a concomitant boost program or with conventional fractionation for cervical cancer patients who did not receive intracavitary brachytherapy. Journal of Radiation Research. 2012 Nov 1;53(6):900-5.

Kadkhodayan S, Shandiz FH, Toussi MS, Aghaee MA, Farshidi F, Dehghan P. Concurrent chemoradiotherapy without brachytherapy in locally advanced cervical cancer. Iranian Journal of Cancer Prevention. 2013;6(4):195.

Mazzola R, Ricchetti F, Fiorentino A, Levra NG, Fersino S, Di Paola G, Ruggieri R, Alongi F. Weekly cisplatin and volumetric-modulated arc therapy with simultaneous integrated boost for radical treatment of advanced cervical cancer in elderly patients: feasibility and clinical preliminary results. Technology in Cancer Research & Treatment. 2017 Jun;16(3):310-5.

Kim H, Kim YS, Joo JH, Eom KY, Park W, Kim JH, Lee JH, Kim YS, Lee SH, Ahn K, Kim YB. Tumor boost using external beam radiation in cervical cancer patients unable to receive intracavitary brachytherapy: outcome from a multicenter retrospective study (Korean radiation oncology group 1419). International Journal of Gynecologic Cancer. 2018 Feb 1;28(2).

Delgado D, Figueiredo A, Mendonça V, Jorge M, Abdulrehman M, de Pina MF. Results from chemoradiotherapy for squamous cell cervical cancer with or without intracavitary brachytherapy. Journal of Contemporary Brachytherapy. 2019 Oct;11(5):417.

Lazzari R, Riva G, Augugliaro M, Vavassori A, Dicuonzo S, Cattani F, Comi S, Colombo N, Jereczek-Fossa BA. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy. International Journal of Gynecologic Cancer. 2020 May 1;30(5).

Lax I, Blomgren H, Näslund I, Svanström R. Stereotactic radiotherapy of malignancies in the abdomen: methodological aspects. Acta Oncologica. 1994 Jan 1;33(6):677-83.

Haas JA, Witten MR, Clancey O, Episcopia K, Accordino D, Chalas E. CyberKnife boost for patients with cervical cancer unable to undergo brachytherapy. Frontiers in Oncology. 2012 Mar 21;2:25.

Hsieh CH, Tien HJ, Hsiao SM, Wei MC, Wu WY, Sun HD, Wang LY, Hsieh YP, Chen YJ, Shueng PW. Stereotactic body radiation therapy via helical tomotherapy to replace brachytherapy for brachytherapy-unsuitable cervical cancer patients–a preliminary result. OncoTargets and therapy. 2013;6:59.

Marnitz S, Köhler C, Budach V, Neumann O, Kluge A, Wlodarczyk W, Jahn U, Gebauer B, Kufeld M. Brachytherapy-emulating robotic radiosurgery in patients with cervical carcinoma. Radiation oncology. 2013 Dec;8(1):1-8.

Mantz CA. Stereotactic body radiation therapy as a boost alternative for nonmetastatic cancer of the cervix and endometrium: disease control and quality of life outcomes from a phase 2 trial at 3 years' minimum follow-up. International Journal of Radiation Oncology, Biology, Physics. 2016 Oct 1;96(2):E286.

O'Donnell B, Shiao JC, Pezzi TA, Waheed N, Sharma S, Bonnen MD, Ludwig MS. Stereotactic body radiation therapy, intensity-modulated radiation therapy, and brachytherapy boost modalities in invasive cervical cancer: a study of the National Cancer Data Base. International Journal of Gynecologic Cancer. 2018 Mar 1;28(3).

Albuquerque K, Tumati V, Lea J, Ahn C, Richardson D, Miller D, Timmerman R. A phase II trial of stereotactic ablative radiation therapy as a boost for locally advanced cervical cancer. International Journal of Radiation Oncology* Biology* Physics. 2020 Mar 1;106(3):464-71.

Most read articles by the same author(s)